Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Lifco Ab ( ($SE:LIFCO.B) ).
Lifco AB has announced the acquisition of a majority stake in Nobil Bio Ricerche, an Italian company specializing in customizing implant surfaces for dental manufacturers. This acquisition, set to be consolidated in Lifco’s Dental business area by the fourth quarter of 2025, is not expected to significantly impact Lifco’s financial performance for the current year. The move aligns with Lifco’s strategy of expanding its portfolio in niche markets, potentially enhancing its industry positioning and offering additional growth opportunities.
The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK365.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.
More about Lifco Ab
Lifco is a company that provides a stable environment for small and medium-sized businesses, focusing on acquiring and developing market-leading niche businesses. The company operates in three main business areas: Dental, Demolition & Tools, and Systems Solutions. Lifco emphasizes long-term growth, profitability, and a decentralized organizational structure. As of the end of 2024, Lifco comprised 257 operating companies across 34 countries, with significant financial performance metrics including an EBITA of SEK 5.9 billion and net sales of SEK 26.1 billion.
Average Trading Volume: 311,191
Technical Sentiment Signal: Hold
Current Market Cap: SEK146.8B
Learn more about LIFCO.B stock on TipRanks’ Stock Analysis page.